Sign up to save your podcasts
Or
Share 78: Navigating the Glaucoma Therapeutic and Surgical Landscape from Conventional to Cutting Edge
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
78: Navigating the Glaucoma Therapeutic and Surgical Landscape from Conventional to Cutting Edge
Episode Description
In this podcast, experts Deborah Ristvedt, DO; and Melissa Tawa, OD, FAAO, discuss individualizing glaucoma therapy with selective laser trabeculoplasty and sustained-release drug implants, providing key take-home insights for optimizing glaucoma management across diverse patient profiles.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
Assess non-topical therapies available for management of ocular hypertension and open angle glaucoma, including laser procedures and sustained drug delivery options
Implement the latest advances in minimally invasive glaucoma surgery in appropriate patients
Acknowledgment of Educational Grant Support
This activity is supported by an educational grant from Glaukos Corporation and Sun Pharmaceutical Industries, Inc.
Chair
Deborah Ristvedt, DO
Anterior Segment Surgeon
Vance Thompson Vision
Alexandria, MN
Disclosures: Consultant: AbbVie, BVI Medical, Glaukos, Johnson & Johnson Surgical Vision, RxSight, Sight Sciences; Speakers Bureau: AbbVie, BVI Medical, Glaukos, Johnson & Johnson Surgical Vision, RxSight, Sight Sciences.
Faculty
Melissa Tawa, OD, FAAO
Assistant Professor
Southern California College of Optometry
Marshall B. Ketchum University
Anaheim, CA
Disclosures: Melissa Tawa, OD, FAAO, has no relevant financial relationships with ineligible companies.
Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME Guidelines, PER® has identified and resolved all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
This podcast was developed by PER® editorial staff based on an online activity developed with these faculty.
To learn more about this topic, including information on newer mechanisms of action for topical glaucoma therapies, go to https://www.gotoper.com/courses/navigating-the-glaucoma-therapeutic-and-surgical-landscape-from-conventional-to-cutting-edge
Release Date
June 30, 2025
Expiration Date
June 30, 2026
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
View all episodes
By Optometry Times On the AirEpisode Description
In this podcast, experts Deborah Ristvedt, DO; and Melissa Tawa, OD, FAAO, discuss individualizing glaucoma therapy with selective laser trabeculoplasty and sustained-release drug implants, providing key take-home insights for optimizing glaucoma management across diverse patient profiles.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
Assess non-topical therapies available for management of ocular hypertension and open angle glaucoma, including laser procedures and sustained drug delivery options
Implement the latest advances in minimally invasive glaucoma surgery in appropriate patients
Acknowledgment of Educational Grant Support
This activity is supported by an educational grant from Glaukos Corporation and Sun Pharmaceutical Industries, Inc.
Chair
Deborah Ristvedt, DO
Anterior Segment Surgeon
Vance Thompson Vision
Alexandria, MN
Disclosures: Consultant: AbbVie, BVI Medical, Glaukos, Johnson & Johnson Surgical Vision, RxSight, Sight Sciences; Speakers Bureau: AbbVie, BVI Medical, Glaukos, Johnson & Johnson Surgical Vision, RxSight, Sight Sciences.
Faculty
Melissa Tawa, OD, FAAO
Assistant Professor
Southern California College of Optometry
Marshall B. Ketchum University
Anaheim, CA
Disclosures: Melissa Tawa, OD, FAAO, has no relevant financial relationships with ineligible companies.
Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME Guidelines, PER® has identified and resolved all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
This podcast was developed by PER® editorial staff based on an online activity developed with these faculty.
To learn more about this topic, including information on newer mechanisms of action for topical glaucoma therapies, go to https://www.gotoper.com/courses/navigating-the-glaucoma-therapeutic-and-surgical-landscape-from-conventional-to-cutting-edge
Release Date
June 30, 2025
Expiration Date
June 30, 2026
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.